title: A genetic etiology of pervasive developmental disorder guides treatment.
authors.affiliation: Department of Psychiatry and Behavioral Sciences, MIND Institute, University of California, Davis, Sacramento, CA 95817, USA. marjorie.solomon@ucdmc.ucdavis.edu
authors.forename: Marjorie
authors.initials: M
authors.lastname: Solomon
authors.forename: David
authors.initials: D
authors.lastname: Hessl
authors.forename: Sufen
authors.initials: S
authors.lastname: Chiu
authors.forename: Randi
authors.initials: R
authors.lastname: Hagerman
authors.forename: Robert
authors.initials: R
authors.lastname: Hendren
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D001289:Attention Deficit Disorder with Hyperactivity / Q000188:drug therapy / Q000453:epidemiology / Q000235:genetics; D001321:Autistic Disorder / Q000235:genetics / Q000628:therapy; D002648:Child; D002659:Child Development Disorders, Pervasive / Q000453:epidemiology / Q000235:genetics / Q000628:therapy*; D015897:Comorbidity; D005260:Female; D005600:Fragile X Syndrome / Q000453:epidemiology / Q000235:genetics / Q000628:therapy; D006801:Humans; D009788:Occupational Therapy / Q000379:methods; D010641:Phenotype; D011613:Psychotherapy / Q000379:methods; D017367:Selective Serotonin Reuptake Inhibitors / Q000627:therapeutic use; D020280:Sertraline / Q000627:therapeutic use
chemical_list: D017367:Selective Serotonin Reuptake Inhibitors; D020280:Sertraline